Back to search
Schizophrenia, Schizotypal and Delusional Disorders
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Schizophrenia, Schizotypal and Delusional Disorders trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Schizophrenia, Schizotypal and Delusional Disorders trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Although psychotic disorders typically affect less than 1% of the population, they are a significant cause of disability worldwide. Psychotic symptoms such as h…
The OPUS YOUNG (OY) study investigates the efficacy of early intervention service versus treatment as usual (TAU) for adolescents aged 12-17 years with a first-…